logo
15:59 May 29

Novartis India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1556.60
+68.90 (+4.63%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Novartis India Ltd. Financials

Novartis India Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1556.60
+68.90 (+4.63%)
15:59 May 29
Quality
image/svg+xml

63/100
High Financial Strength

Valuation
image/svg+xml

25/100
Expensive Valuation

Technical

75/100
Technically Bullish

Strength

9

Weakness

4

Opportunity

0

Threats

0

11.39 %

ROE %

9.52 %

ROA %

37.74

EPS

331.37

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
399.87 378.74 335.07 356.27 354.33
Operating Expenses +
372.76 313.66 269.81 264.85 260.23
Raw Material
187.26 199.34 189.98 199.07 210.58
Increase Decrease in Cost
-9.13 2.35 9.86 3.75 -12.21
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
101.89 35.64 22.96 18.72 21.08
Miscellaneous Expenses
467.26 475.01 426.97 441.45 461.94
Operating Profit
27.11 65.08 65.26 91.42 94.1
Other Income
33.19 58.11 61.68 41.96 38.77
Depreciation
9.65 6.06 2.61 2.19 1.95
Interest
4.83 1.75 1.49 0.77 1.26
Profit before tax and exceptio..
45.82 115.38 122.84 130.42 129.66
Exceptional Items
-49.64 0 0 0 0
PBT
-3.82 115.38 122.84 130.42 129.66
Provision for Taxation
-0.1 12.02 37.65 29.52 36.48
Net Profit
-3.72 103.36 85.19 100.9 93.18
NET Profit after MI
0 0 0 0 0
EPS
-1.51 41.86 34.5 40.87 37.74
Operating Profit Margin (%)
6.78 17.18 19.48 25.66 26.56
Net Profit Margin (%)
-0.93 27.29 25.42 28.32 26.3

Novartis India Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 70.70 70.70 70.70 70.70 70.70 70.70
FII 0.20 0.20 0.20 0.20 0.20 0.20
Public 0.50 0.60 0.50 0.50 0.50 0.50
Others 28.60 28.50 28.60 28.60 28.60 28.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: